Animal Health
Biotech
GMP
Intellectual Property
Legal
Management Skills
Medical Devices
Pharmaceutical
Support Staff

Sponsoring & Exhibiting

For sponsorship and exhibition opportunities at Management Forum events click here

Event Management

To find out about event management click here

Speaking Opportunities

Speaking opportunities are available on selected Management Forum events, please contact us for further information

Management Forum Brochure

Download our catalogue here

Pharmaceutical Medical Devices

Injectable Drug Delivery

21-22 Mar 2017

Standard
Excluding VAT @ 20.00%

Venue: Le Meridien Piccadilly Hotel, London

Enrol now

Bespoke training

We can customise this course to meet the requirements of your organisation.

Learn more

Course Overview

Advances in Technology for pens, auto-injectors, needle-free, pre-filled syringes and other parenteral methods, plus a regulatory update

The pharmaceutical industry continues to face huge change with the world’s largest selling drugs having switched from oral small molecules (tablets), taken by millions of patients costing about £1 per day to biologics, taken by fewer people but costing many times as much. Four of the world’s five top selling drugs are now delivered by injection or infusion and the remaining member of the top 5 list is inhaled. Thus the world’s 5 top selling drugs all require a device to effect delivery.

Since injections have never been particularly popular with patients, the emphasis is increasingly on making patients take their drugs by applying ergonomic factors and compliance monitoring to drug delivery. This conference will discuss the state-of-the-art technology being applied in the parenteral field and will look at advances in compliance monitoring.

Also of interest

We are running the sister event to this meeting Pre-Filled Syringes this March and if you require more information on this or any other meeting please call Customer Services on +44 (0)20 7749 4730 or e-mail info@management-forum.co.uk

Why you should attend

  • Hear the latest technology in the injectable drug delivery arena
  • Establish where this fast moving market is going and the innovations being applied for patient compliance
  • Network with your peers and increase your business partnership potential

Who should attend

This conference will be of particular interest to:
Scientists and management in medical devices, pharmaceutical and biotechnology companies working in parenteral delivery. Personnel responsible for device programmes, product development, regulatory affairs and product lifecycle management will find this event beneficial. Previous delegates include: Directors, Senior Executives in R&D, Head of Device Departments, Combination Products Specialists, Drug Delivery Managers, Business Development Executives, Product Development Managers and those in Project Co-ordination and Marketing roles.

Programme Day One

09.00 Registration and coffee

09.30 Chairman’s Welcome and Introduction
Dr Gregory Berman, Head of Medical, Kinneir Dufort, UK

09.40 Speeding up Time to Market with Platform Products and Customer-Specific Customization of Pens and Auto-injectors

  • New pharma demands for complex injection devices
  • Usability and design considerations for pen and autoinjector devices
  • Advantages of large scale automated manufacture of pen injector and autoinjector subassemblies

Ian Thompson, Vice President Business Development, Ypsomed, UK

10.20 Lifecycle Management: the Bydureon Pen

  • Challenges and opportunities

Josie Wright, Principal Scientist (Device Development), AstraZeneca, UK

11.00 Discussion

11.10 Refreshments

11.30 Novel Aseptic Foil Sealing Development for a New Auto-Injector

  • Challenges and demands expected for aseptic manufacturing of this device
  • The technology and how we developed the solution

Simon Strothers, Director, 3PInnovation, UK and Matthew Young, Chief Technology Officer, Oval Medical Technologies, UK

12.10 Trends Towards Large Volume Pumps

Tony Bedford, Head of Medical Business Development, Kinneir Dufort, UK

12.50 Discussion

13.00 Lunch

14.10 Transforming the Patient Experience with a Computer-Controlled Needle-Free Device

  • Delivering high viscosity, high concentration biologics is a challenge for the biopharma industry. Injections are slow and painful, and patients don’t like needles. Drug adherence is a problem and safety concerns are real
  • The Portal device offers a transformed patient experience. The injection is needle-free, fast, imperceptible and the device is easy to use. It is also agnostic to the drug’s viscosity and concentration via computer control
  • We will present our pre-clinical data and early results from our patient tolerability study

Patrick Anquetil, CEO & Co-Founder, Portal Instruments, USA

15.00 Injected Drug Delivery: The Challenge and Opportunity Offered by Connectivity

  • Brief introduction to Connected Health
  • Patient Support Programmes enabled by Connectivity
  • Perspectives of stakeholders: Patients, Clinicians, HCPs, Pharma, Payers Incentives and Barriers
  • Device Connectivity models and architectures.

Diarmuid Quinn, Director of Sales and Business Development, Connected Health Solution Design, S3 Group, Ireland

15.30 Discussion

15.40 Refreshments

16.00 SteadyMed’s Patchpump TM Technology

  • A wearable, discreet, water-resistant and disposable drug administration technology
  • Design & manufacturing status of Trevyent for Pulmonary Arterial Hypertension
  • Next generation PatchPump concepts

Assaf Shaked, Senior Manager, Device Development, SteadyMed Therapeutics, USA

16.40 The Requirements and Unique Challenges in the Testing of On-Body Delivery Systems

  • Summary of Draft ISO 11608-6 Standard on On-Body Delivery Systems
    • Device and Pharmaceutical Requirements
  • Regulatory approval paths – USA/EU
  • Pump vs. Injector
  • Unique Challenges
    • Sterilization/Sterility
    • Product Contact – Reservoir, fluid path
    • Adhesives – retention, removal and skin reactions
    • Filling
    • Usability

Lee Leichter, President P/L Medical, USA

17.20 Discussion

17.30 End of Day One

19.30 Drinks reception followed by dinner for delegates and speakers at Le Meridien Hotel, London

Programme Day Two

09.00 Review of Day One

Dr Gregory Berman, Head of Medical, Kinneir Dufort, UK

09.10 What do Pharma Companies Want from Device Manufacturers?
Speaker (invited)

09.50 Get Out There and Listen

  • Why medical devices have to be desirable, as well as safe and effective, to compete in their competitive set
  • Should human factors include emotional factors?
  • Does your medical device have a competitive advantage?
  • Should medical devices be thought of as brands?
  • How successful devices from other industries are the ones that bond emotionally (as well as deliver functionally)
  • Good and bad examples from other industries

Craig Scott, Director, Greensand and Martin Schlaeppi, Director, Greensand, UK

10.30 Discussion

10.40 Refreshments

11.10 Improving Adherence for Injectable Drugs

  • Importance of adherence, outcomes and connected health
  • Economic and health impact of non-adherence in the market today
  • Historic approaches to improving adherence
  • Case studies of Connected Health approaches to adherence
  • Strategies for implementing solutions for injection devices

Zach Marks, Director, Delivery Systems Marketing, West Pharmaceutical Services, USA

11.50 Leveraging a Device Platform – Some of the Considerations

  • What is a ‘platform’ ?
  • Client vs. Provider responsibilities
  • Documentation and structure
  • Risks
  • Change management
  • A Case Study

Mark Chipperfield, Company Director and Principal Consultant, Corvus Device, UK

12.30 Discussion

12.45 Lunch

14.00 High Viscosity, High Volume (HVHV)

  • Current challenges to delivery
  • Overview of existing solutions
  • Modelling HVHV delivery in patient
  • Outlook to 2nd generation solutions

Uri Baruch, Head of Drug Delivery, Cambridge Design Partnership, UK

14.40 User Interface (UI) Design Considerations for Electronic Drug Delivery Devices

  • UI design considerations for electronic auto injectors.
  • Opportunities and challenges with injectable drug delivery devices
  • New horizons for healthcare products

Tsachi Shaked, Senior Director of Marketing and Business Development Injectable Drug Delivery Devices Elcam Medical, Israel

15.20 SAN-DVs, Safe Auto-Needles for Use with Drugs in Vials – Combining the SAN-L for Self-Administration or the SAN-Light for Administration by Health Care Professionals

  • Case study showing the products evolution and lessons learnt from human factors studies with patients and Health Care Professionals (HCPs)

David Daily, CEO and Co-Founder and Hagay Drori, Product Manager, DALI Medical Devices, Israel

16.00 Discussion and Chairman’s Closing Remarks

16.15 End of Conference and Tea

You may also be interested in...

Pre-Filled Syringes

Previous customers include...

  • ABBOTT GmbH & Co KG
  • Actavis
  • Advention Business Partners
  • Agency for Medicinal Products and Medical Devices of Croatia (HALMED)
  • Alexion Pharmaceuticals Inc
  • ALK Abello
  • Amgen Europe BV
  • Beaufour Ipsen Industrie
  • Biocorp
  • Celanese Emulsions BV
  • Crospon Limited
  • CSL Behring AG
  • Elcam Medical Ltd
  • Future Injection Technologies Limited
  • Genentech
  • Genetech Inc
  • German Malaysian Medical Industries
  • Ian Smith
  • IGS Gebojagema
  • Merck & Co Inc
  • Oval Medical Technologies Ltd
  • Rexam Healthcare La Verpilliere
  • Roche Diabetes Care AG
  • Rovi Contract Manufacturing S.L.
  • SHL Group
  • Takeda Pharma A/S
  • Team Consulting Ltd
  • TECH GROUP
  • Texchem-Pack (M) Bhd
  • Vetter Pharma International GmbH